MCRB
Seres Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.00
−2.44%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$1.00
- Revenue estimate
- $6.3M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.47
- EPS estimate
- -$2.18
- Revenue actual
- $736.0K
- Revenue estimate
- $179.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +475.3%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | -$2.18 | $0.47 | Beat 121.56% | $736.0K |
| May 5, 2026 | -$1.88 | -$2.08 | Miss -10.64% | $358.0K |
| Mar 12, 2026 | -$2.11 | -$1.89 | Beat 10.43% | $438.0K |
| Nov 5, 2025 | $0.05 | $0.94 | Beat 1780.00% | $351.0K |
| Aug 6, 2025 | -$2.72 | -$2.27 | Beat 16.54% | — |
| May 7, 2025 | -$0.67 | -$2.24 | Miss -234.33% | — |
| Mar 13, 2025 | -$0.17 | -$0.32 | Miss -88.24% | — |
| May 8, 2024 | -$7.20 | -$5.40 | Beat 25.00% | — |
| Mar 5, 2024 | -$8.00 | -$6.40 | Beat 20.00% | $64.0K |
| Nov 2, 2023 | -$9.40 | -$7.40 | Beat 21.28% | $310.0K |
| Mar 7, 2023 | -$8.20 | -$11 | Miss -31.71% | $975.0K |
| Nov 2, 2022 | -$9.00 | -$9.80 | Miss -8.89% | $3.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026